Emmanuel Macron will address the population on Tuesday at 8 p.m.

Emmanuel Macron will address the population on Tuesday, November 9 at 8 p.m., while a resumption of the Covid-19 epidemic is confirmed in France. This speech, undoubtedly in the wake of a health defense council, will be the head of state’s first since that of July 12 and will take place five months before the first round of the presidential election, on April 10, 2022.

Read also: Article reserved for our subscribers While waiting for her candidate, Macronie is looking for her course

It should be on the same format as that of the beginning of the summer, including a part “On the health situation” and another “On the economic recovery, the reforms which are being carried out and on all the subjects which cross our country today”, according to government spokesperson Gabriel Attal.

A resumption of the “slight, but certain” epidemic

“Europe has once again become the epicenter of the epidemic” with some “Sometimes spectacular covers (…) In France, we are seeing a slight recovery at this stage, but certain ”, noted Mr. Attal on Friday during a visit to a Paris pharmacy, where he attended the administration of a third dose of the vaccine to a 67-year-old woman. “We are facing a hedge, the height of which we do not know. But we have the tools to cross it ”, he added.

Read also: Article reserved for our subscribers How purchasing power became the government’s big fear

On July 12, Mr. Macron notably announced the extension of the health pass, which Parliament authorized on Friday the possible use until July 31, 2022.

Tuesday will arise in particular the question of conditioning the health pass to a third dose of vaccine, which has become the workhorse of the government. On Friday in Montpellier, Prime Minister Jean Castex told Agence France-Presse that the executive was considering this track “Without doubt more than the path of compulsory vaccination for those over 65”, promising a “Reply soon”.

Read also Article reserved for our subscribers Covid-19: why the data argue in favor of a vaccination booster in the most vulnerable

The World with AFP